The objectives of this study were to determine the effects of daily injection of bovine somatotropin (bST) on the metabolism of N and 1-[14C]leucine and on hormone and metabolite concentrations in growing beef steers. Injection of bST increased N retention (P < .05) primarily through decreased (P < .10) urinary N excretion. Plasma concentration of somatotropin, insulin and glucose increased (P < .01) and of urea-N (P < .01) and ~-amino-N (P < .10) decreased with bST compared with excipient injection. Total leucine flux was not altered by treatment; however, the partition of flux was. Leucine oxidation decreased (P < .05) and leucine used for protein synthesis (P < .10) increased, with bST compared with excipient injection. During excipient injection, 10.3 g protein were synthesized for each gram crude protein deposited, whereas during bST injections only 6.4 g were required. The average maximum contribution of myofibrillar protein degradation to whole body protein degradation, calculated from excretion of 3-methylhistidine, was 16%. Although the ratio of protein deposition/protein synthesis was low for both excipient-and bST-injected steers, the incremental efficiency of protein deposition was 50%, reflecting a dilution of protein synthesis required for turnover and a proportionately greater increase in protein synthesis than protein degradation with bST injection. In growing beef steers, bST stimulated whole body protein synthesis and decreased leucine oxidation. The change in partition of leucine flux, but not of total flux (irreversible loss), demonstrates a chronic redirection in metabolism consistent with homeorhetic control These data from steers injected with bST suggest mechanisms by which bST affects metabolism during normal growth.
Introduction
The effectiveness of bovine somatotropin (bST) to alter metabolic processes may vary with stage of growth and(or) rate of growth. For example, young dairy heifer calves treated for 21 wk with bST showed increased daily gain but not increased N retention or altered carcass composition (Sandles and Peel, 1987) . Older dairy steers showed improved N retention (Moseley et al., 1982) , although this study was short-term.
We previously demonstrated that beef heifers (368 kg BW) increased N retention and whole body protein synthesis when injected with bST compared with excipient injections (Eisemann et al., 1986a, b) . Injections of bST did not alter protein degradation. These heifers were fed slightly above maintenance energy (ADG 186 g/d) with adequate N to support live weight gains of 300 g/d. These changes occurred with no change in N intake.
Improved N retention may reflect increased protein synthesis and(or) decreased protein degradation. The objectives of this study were to determine whether bST altered protein metabolism in a similar fashion in more rapidly growing beef steers and to measure effects of daily injection of bST on hormone and metabolite concentrations.
Materials and Methods
Animals and Diets. Twelve Hereford • Angus steers (295 + 5 kg BW) were used in the study. They were weaned at approximately 6 mo of age onto a pelleted orchardgrass hay diet and housed in individual pens in an open-air barn. Steers were weighed three times/week and feed intake was recorded daily for 6 too, until steers were switched to the experimental protocol. Based on BW and rate of gain throughout the preliminary period, steers were paired for the experiment. For logistical reasons, the treatment sequence was staggered for each pair of steers. The experiment began in November 1983 and continued for 6 mo.
Four weeks before treatment initiation, steers were gradually (1 wk) changed to the experimental diet (Table 1) . The diet was a completely mixed, pelleted feed formulated to meet the nutritional requirements of growing steers 9 Lot 14 Miles Laboratories, Naperville, IL. bAdded at 2,000 IU, 300 IU and 11 IU/kg respectively.
(NRC, 1986). The feed contained 2.49 Mcal ME/kg (calculated, NRC 1976) and 12.7% crude protein on a dry matter basis. The diet was fed at .234 Mcal ME/kg BW "Ts. Feeding was six times/day, at equal intervals, for at least 1 wk before treatment initiation. Amount of feed offered and refused was recorded daily, and the amount of feed offered was adjusted weekly. During the treatment period, steers were weighed on two consecutive days each week except during balance trials, when they were weighed once.
Design. The design of the study was a balanced single reversal with two periods, excipient or bST. Daily s.c. injections (neck region) of excipient or bST were for 14 d. Injections were given daily at 0900 in a volume of 14 ml. The bST dose was 29.2 IU/d 9 (1.3 IU/mg protein). Bovine ST was dissolved in sterile buffer composed of equal parts .025 M NaHCO3 and .025 M Na2CO3 in .15 M NaC1 (pH adjusted between 9.3 to 9.4) with 25 mg thimerosal (antibacterial agent) added/liter. Solutions were prepared on a weekly basis and stored at 4~ until used.
Following the second 2-wk injection period, steers were maintained on their second treatment for an additional 5 or 6 d before slaughter. By administering bST for 2 to 3 wk, we were addressing chronic, although short-term, metabolic effects of bST.
Balance Trials. On the morning of d 6 of treatment, steers were moved to metabolism crates in preparation for N balance measurements. Balance trials were conducted from d 9 to 13 of treatment. Urine was acidified during collection. Feed offered and refused, total urine and feces were quantified daily, mixed and sampled. Feed samples were stored at room temperature and urine and feces samples were stored at -20~ until the end of the 5-d collection period. At the end of the collection period, daily samples were mixed and an aliquot taken for chemical analysis. Nitrogen content was determined on wet samples by macro-Kjeldahl (AOAC, 1980) . Dry matter content of feed samples was determined by drying for 24 h at 100-C.
Excretion of creatinine, hydroxyproline and 3-methylhistidine was measured in the combined urine aliquot obtained during total collection. Analysis of 3-methylhistidine and hydroxyproline were as previously described (Eisemann et al., 1986b) . Creatinine was analyzed by automated procedures 1~ based on a modified Jaffe reaction (reaction of saturated picric acid with creatinine in the presence of alkali).
Blood Sampling. Catheters were inserted into a jugular vein on d 13 of treatment after steers were moved from the metabolism crates and before they were returned to their pens. milliliter blood samples were collected at 20-min intervals for an 8-h period using heparinized syringes. Plasma samples were stored at -20~ until analysis.
Plasma metabolite concentrations were determined by automated procedures on a pooled sample from three consecutive 20-min blood samples (eight samples/steer for each sampling period). Glucose was determined by a glucose oxidase procedure 13, urea-N 14 by the diacetylmonoxime method (Marsh et al., 1965) , ammonia by a hypochlorite method is, a-amino-N as described by Broderick and Kang (1980) with addition of a 61-cm type-C dialyzer to allow analysis of whole plasma, and creatinine as described above for urine.
Plasma concentration of bST was determined on each 20-min blood sample. Insulin was analyzed on an hourly pooled sample. Plasma concentrations of bST and insulin were measured by specific double antibody radioimmunoassay (Elsasser et al., 1986) .
Leucine Infusion. On d 18 of the second treatment period, approximately 15 cm of catheter (as previously described) was inserted into both jugular veins of each steer. On d 19 or 20, one steer of each pair was moved to a metabolism crate for leucine infusion (only one steer could be infused/day). NaC1 was added to a stock solution of L-l-[14C]leucine (specific radioactivity, SRA, 57 mCi/mmo116) to a final concentration of .15 M. A syringe infusion pump 17 was used for a 380-rain continuous isotope infusion (5.7/aCi/min) into one jugular vein. Blood was collected at 20-min intervals from the catheter in the contralateral jugular vein. Protein-free plasma filtrates were prepared and analyzed for radiolabeled and total leucine to determine leucine SRA as described previously (Eisemann et al., 1986a ). An aliquot of filtrate from the first three blood samples was pooled for analysis of concentration of individual amino acids by ion exchange chromatography. A three-buffer analysis method was used incorporating S-B-(4-pyridylethyl)-L-cysteine as the internal standard is.
During infusions, the steer's head was confined in a respiration box attached to the metabolism crate, as described by Rurnsey (1969) with the following modifications. Two pressure-vacuum air pumps x9 with the displacement of 103 liters/min each pulled air through the plexiglass box for collection of expired CO2. Volume of the respiration box was 620 liters, and the turnover time was 3 min. The output of each pump was split between a gas meter u~ calibrated before the study, and a flow meter 21 (approximately 99.5 and .5% of total flow, respectively). The exit end of each flow meter was connected to three traps in series for collection of CO2, which were connected in series to a wet test meter u2. The wet test meter was used to determine volume of air through the traps. There were four or five 20-rain collection periods spaced evenly throughout the isotope infusion.
The trapping solution for CO2 was a 2:1 (v:v) solution of 2-methoxyethanol and ethanolamine. Three milliliters of trapping solution were combined with 16 ml of a 10:6 (v:v) solution of toluene scintillation fluid (160 ml Permafluor I z~ per 3.8 liters scintillation grade toluene) and 2-methoxyethanol. Radioactivity was quantified by liquid scintillation using external standard channels ratio to determine counting efficiency.
At the end of infusion, steers were killed (by injection of an euthanasia solution) and body components separated into carcass and noncarcass fractions. These fractions were ground, and four samples were taken of each fraction. The samples were lyophilized for 4 d at 32~ and reground with dry ice in a Wiley mill through a 2-mm sieve. Aliquots were removed for chemical analysis. Nitrogen was determined by macro-Kjeldahl (AOAC, 1980) on two sample aliquots. Fat was removed from two sample aliquots by ether extraction (AOAC, 1980) . The ether-extracted residue was divided into two fractions. Ash was determined on one fraction as the residual sample remaining after approximately 14 h at 550~
The remaining fraction was hydrolyzed in 6 N HC1 for 24 h at 105~
Norleucine was included as an internal standard. Following hydrolysis, HC1 was evaporated and the residue reconstituted in .1 N HC1 for analysis of L-leucine and norleucine by ion exchange chromatography is. The sample used for hydrolysis was corrected for ash content. The proportion of N in carcass and noncarcass tissues was used to convert leucine content of body protein in the two tissue fractions to a whole body concentration. Average -+ SEM values were: N in carcass tissues, 4.96 -+ .07 kg; N in noncarcass tissues, 2.56 -+ .06 kg; leucine content of carcass protein, 67.9 -+ 2.2 mg/g; and leucine content of noncarcass protein, 62.6 -+ 1.2 mg/g. Calculated leucine content of whole body protein was 66.0 + 1.7 mg/g.
For both plasma leucine and expired CO2 SRA, the plateau value for each steers was determined by fitting data points to a single-component negative exponential function:
where S is the SRA of plasma leucine or expired CO2 at time t, Sma x is the value of S at plateau, and X is the fractional turnover rate. The actual and predicted values for leucine SRA and COa SRA for one pair of steers are shown in Figure  1 . Plateau estimates were used for all calculations.
Plasma leucine (Leu) irreversible loss was calculated by dividing the infusion rate (nCi/min) by the plateau Leu SRA (nCi/mmol).
Oxidation (mmol/min) = ([SRA CO2 (nCi/mg atom C)] + [SRA Leu (nCi/mg atom C)]) x CO2 production (mmol/min) Leucine oxidation was subtracted from irreversible loss to obtain a corrected flux value for calculation of protein synthesis on the assumption that loss occurs only by incorporation of leucine into protein and by catabolism. Data of Early et al. (1987) indicate that net release of t~-ketoisocaproate, (the a-keto acid derived from transamination of leucine) was insignificant relative to net uptake of leucine by tissues of the hindlimb in fed cattle.
Protein synthesis (g/d) = Leucine content of whole body protein, 66 mg leucine/g protein, was obtained from analysis of samples from this study.
Using plasma SRA as the SRA of the precursor pool from which protein is synthesized is an assumption underlying this method (Waterlow et al., 1978) . There is controversy over this assumption and the extent to which plasma or intracellular SRA approximates that of leucyl-tRNA. The closeness of either estimate may vary among tissues (for example, see Airhart et al., 1974; Everett et al., 1981) . Whole body protein synthesis calculated from plasma leucine irreversible loss should provide a minimum estimate of synthesis.
Statistical Analysis. For variables related to N balance, urinary metabolite excretion, and plasma hormone and metabolite concentration (except for individual amino acids) measurements were taken on each steer on both treatments (Tables 2 and 3 ). Therefore, self-pairing on the two treatments was used, and a t-statistic was calculated for each variable.
For variables related to individual amino acid concentration and protein metabolism, measurements were made on the final treatment only (Tables 4 and 5 ). Steers were paired based on the initial criteria of body weight and rate of gain. A t-statistic was calculated for each variable based on steer pairs. Data from two steers (one pair) was deleted from the analysis of amino acids and protein metabolism because of problems encountered during isotope infusion.
Results and Discussion
Body weight, dry matter and, consequently, N intake (Table 2) were similar during excipient and bST injection periods. Average + SEM daily gain of the steers during the entire 5-wk experiment was .99 + .05 kg/d. Bovine ST injection resulted in an increase (P < .05) in N retention and a corresponding decrease (P < .10) in urinary excretion of N with no change in the apparent digestibility of N. Thus, in the present study, bST enhanced N retention in young, growing beef steers. This observation is consistent with previous observations in cattle (Car et al., 1967; Znidar, 1976 bType I error probability. NS = P > .10.
Grantley-Smith et al., 1983); however, Sandles and Peel (1987) did not observe an increase in N retention in very young dairy heifers. The study of Sandles and Peel (1987) differed relative to both age and sex of the animals and level of nutrition. Because the major effect of bST in altering N metabolism is postabsorptive, several other indicators of postabsorptive metabolism were evaluated (Table 3) . Urinary excretion of creatinine, 3-methylhistidine and hydroxyproline did not differ with injection period. Creatinine is an end-product of creatine metabolism in muscle and is an index of total muscle mass. When a difference does occur, it is used to adjust excretion of other metabolites to similar apparent muscle mass (Young and Munro, 1978) .
Hydroxyproline is a posttranslational modification of proline in collagen protein (Prockop and Kivirikko, 1967) and has been used as an index of collagen turnover. Three methylhistidine is a component of actin and some species of myosin (Young and Munro, 1978) . Harris and Milne (1981) validated that 3-methylhistidine is quantitatively excreted in the urine and not reincorporated into myofibrillar protein in cattle. Controversy remains over the extent to which tissues other than skeletal muscle contribute to daily 3-methylhistidine excretion (Nishizawa et al., 1977; Millward et al., 1980; Harris, 1981; Wassner and Li, 1982) . Excretion of hydroxyproline and 3-methylhistidine was not altered in heifers in response to injection with bST (Eisemann et al., 1986b) . These data suggest no change in col- bType I error probability. NS = P > .10.
eAverage concentration of branched-chain amino acids.
dAverage concentratin of esstential amino acids, valine, methionine, isoleucine, phenylalanine, lysine, histidine, arginine and leucine. lagen or myofibrillar protein degradation that can account for increased N retention in response to injection with bST.
Daily injections of bST increased (P < .01) average plasma concentration of bST and insulin (Table 3) . Plasma concentration of glucose increased (P < .01) and of urea-N (P < .01) and a-amino-N (P < .10) decreased with somatotropin compared to excipient injection. Plasma glucose for both excipient-and bST-treated animals appear high relative to literature values. Plasma concentration of ammonia and creatinine bType I error probability. NS = P > .10.
CCalculated whole body protein degradation = PS -(N retention • 6.25).
dCp deposited = N retention X 6.25.
were not altered by treatment. Concentrations of amino acids were not affected by treatment except for valine (P < .08), methionine (P < .05), leucine (P < .10) and histidine (P < .05), which decreased with chronic injection of bST compared with excipient (Table 4) . Effects of chronic treatment with exogenous ST to increase glucose or insulin concentrations in growing sheep (Davis et al., 1969; Wagner and Veenhuizen, 1978; Johnsson et al., 1985 Johnsson et al., , 1987 , cattle (Wolfrom and Ivy, 1985; Eisemann et al., 1986a) and pigs (Chung et al., 1985) are documented and suggest alterations in carbohydrate and lipid metabolism. Decreased responsiveness of target cells to insulin following ST injection was demonstrated by a diminished hypoglycemic response to an insulin challenge in fasted wethers (Hart et al., 1984) and a decrease in the amount of exogenous glucose required to maintain plasma glucose concentration during insulin infusion in fasted barrows (Wray-Cahen et al., 1987) .
Decreased plasma urea-N or a-amino-N concentrations were observed under other conditions in which N accretion was stimulated. For example, trenbolone acetate decreased plasma urea concentration (Galbraith, 1980) and the total of urea synthesis and recycling (Donaldson and Heitzman, 1983) in beef heifers. Also, long-term treatment with clenbuterol decreased urea-N concentration in steers (Ricks et al., 1984) . A general trend for decreased concentration of essential amino acids was reported in steers in response to implantation with diethylstilbestrol (Ohjen and Lehmann, 1968; Ohjen et al., 1973) . Interestingly, with diethylstilbestrol implants, histidine did not follow this general trend, whereas it was decreased markedly by bST in the present study. Although there was a decrease or trend for a decrease in concentration of most amino acids in the present study, the proportionate contribution of individual essential amino acids to total essential amino acids was not changed (P > . 10) with ST treatment (data not shown). Decreased concentration could reflect an increase in removal from or decrease in entry to the plasma pool as an acute response to treatment. However, relative to chronic changes, concentration and total irreversible loss are not related.
Chronic daily injection of ST compared with excipient resulted in decreased (P < .10) plasma concentration of leucine with no change in total irreversible loss (Table 5) . Concomitantly, leucine oxidation to CO2 decreased (P < .05), but total CO2 production was not changed, with ST compared with excipient injection. Leucine oxidized decreased (P < .01) from 18.7% of total flux during excipient to 12.4% during bST injections. For each .1 mmol/min increase in irreversible loss, there was an increase in oxidation of .033 and .016 mmol/min during excipient and bST injections, respectively (Figure 2 ). These changes show amino acid conservation coupled with increased capacity of tissues to use leucine in response to bST.
Correcting leucine irreversible loss for oxidation, calculated whole body protein synthesis increased 11% (P < .10) with ST compared with excipient injection. Pell and Bates (1987) reported an increase in the fractional rate of protein synthesis in biceps femoris muscle but not in semitendinosis in growing lambs treated with ST for 12 wk. The decrease in leucine oxidized with bST compared with excipient injections is equivalent to 16 g N/d which more than accounts for the extra leucine required to support the increase in N retention with bST. This suggests a simultaneous increase in whole body protein degradation, although whole body protein degradation was not altered (P > .10) with bST treatment (Table 5) .
If all 3-methylhistidine excreted (Table 3 ) was from skeletal muscle and the concentration in muscle protein was 3.51 #mol/g (Nishizawa et al., 1979) , then myofibrillar protein degradation contributed only 17.2 and 15.4% to calculated whole body protein degradation for excipient and bST injected steers, respectively. These data in growing beef steers are qualitatively similar to previous observations of response to bST injections in heifers fed at slightly above maintenance energy (Eisemann et al., 1986a) . As mentioned previously, other tissues such as the gastrointestinal tract may make a substantial contribution to urinary excretion of 3-methylhistidine, and thus these values are an upper estimate of skeletal muscle contribution to whole body protein degradation. Obviously, other body tissues, such as the gastrointestinal tract, liver and other nonskeletal muscle tissues make major contributions to daily protein degradation in the whole body. Consideration of these other tissues is critical to the regulation of whole body protein turnover.
On a whole body basis, there was a trend for improvement in the number of grams of protein synthesized/gram of protein deposited, from 10.3 during excipient injection to 6.4 during injections with bST ( Irreversible Loss. mmol/min Figure 2 . The relationship between leucine irreversible loss and leucine oxidation. For excipient-injected steers (o), the equation describing the relationship is: y = .33x -.08 (R 2 -.96, P < .01); for bST-injected steers (.), the equation describing the relationship is: y = .16x -.02 (R a = .86, P < .05), where y = oxidation (mmol/min) and x = irreversible loss (mmol/min). rocal for discussion of efficiency, the efficiency of protein deposition was 9.7% during excipient and 15.6% during bST injections. A value of 10% was found in heifers (Hammond et al., 1987) fed at approximately two times maintenance energy intake. Values of 5 to 6.5% were obtained (Lobley et al., 1985; Lobley, 1986) in steers gaining slightly less than in the present study.
The incremental efficiency of protein deposition (Adeposition/Asynthesis) for response to bST was 50% for the steers in the present study 24. This should reflect the efficiency of protein deposition with minimal impact from protein turnover. An incremental efficiency above maintenance of 20% in fattening beef steers (Lobley, 1986) and of 46% in young pigs (Reeds et al., 1980) were reported. Thus, incremental efficiencies of protein deposition can be quite high, compared with absolute efficien2aCalculated from protein synthesis values in Table 5 and crude protein deposition data for steers on their second treatment, which averaged 159 and 229 g/d for excipient-and bST-treated steers, respectively.
cy, and reflect the contribution of changes in both protein synthesis and degradation to increased protein deposition.
Data presented in this paper focus on the chronic effects of bST injection on metabolism of N, amino acids and protein. Somatotropin increased whole body retention of N through stimulation of whole body protein synthesis, reflected by the change in partition of leucine flux. Leucine oxidation decreased, demonstrating amino acid conservation. The additional N retained by the steers, in response to bST injections, was deposited with an incremental efficiency of 50%, reflecting a proportionately greater stimulation of protein synthesis than protein degradation. These observations of response to bST in rapidly growing beef steers are qualitatively similar to those previously observed in heifers fed at slightly above maintenance energy intake (Eisemann et al., 1986a, b) . The quantitative difference in response may relate to differences in energy intake. The chronic redirection in metabolism by bST is consistent with homeorhetic control. These mechanisms demonstrated in steers, in response to exogenous bST, give insight into possible mechanisms of growth regulation by bST in normal animals.
